BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →

Loading TECH charts…

Search ticker or company⌘K

TECH

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

TECH · BIO-TECHNE Corp fundamentals · vpside

vpside

⌘K

TECHMarket cap $11.4B/Last filing 10-K/A, FY26 · 28 Oct 2026/TECHMarket cap $11.4B/Last filing 10-K/A, FY26 · 28 Oct 2026/TECHMarket cap $11.4B/Last filing 10-K/A, FY26 · 28 Oct 2026/TECHMarket cap $11.4B/Last filing 10-K/A, FY26 · 28 Oct 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

TECH

BIO-TECHNE Corp

Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 30 Jun

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

$321M+1.3% year on year

$400M$200M$0

vpside.com

Q1 ’22Q2 ’23Q3 ’24Q3 ’25Q4 ’26

Company filings · 10-K filed 24 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

65.8%+1.0 pp year on year

70%68%66%64%

vpside.com

Q1 ’22Q2 ’23Q3 ’24Q3 ’25Q4 ’26

Company filings · 10-K filed 24 Aug 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$265M+63.2% year on year

$300M$200M$100M$0

vpside.com

Q1 ’22Q2 ’23Q3 ’24Q3 ’25Q4 ’26

Company filings · 10-K filed 24 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

$263M+2.6% year on year

$400M$200M$0

vpside.com

Q1 ’22Q2 ’23Q3 ’24Q3 ’25Q4 ’26

Company filings · 10-K filed 24 Aug 2026 · TTM = last four quartersvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters